What Is SLU-PP-332?
SLU-PP-332 is an investigational small molecule—not a peptide—being studied for its ability to activate estrogen-related receptors involved in mitochondrial function and endurance metabolism.
How It Works
It activates ERR pathways regulating mitochondrial biogenesis, fatty acid oxidation, and oxidative metabolism, mimicking some exercise-related adaptations in preclinical models.
Potential Benefits Being Studied
Endurance, metabolic disease, obesity, mitochondrial dysfunction, and healthy aging.
Typical Research Dosing
No standardized human dosing exists; published work is primarily preclinical.
Administration
Administration depends on the research protocol and remains investigational.
Possible Side Effects
Human safety is not established; theoretical risks include cardiovascular and metabolic effects.
Bottom Line
SLU-PP-332 is an early-stage research compound with promising preclinical data but very limited human evidence.